Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693327 · ClinicalTrials.gov registry record
Microbiome and the Gut-Brain Axis
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 58
- Enrollment target
NCT02693327: Completed study, sponsored by University of Florida.
NCT02693327 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02693327 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
This research study will examine the relationship interconnecting medical body health, mental health, and microbes of the digestive tract in persons living with serious mental illnesses,as compared to persons without such disorders. Existing research suggests that interactions between digestive tract microbes and the body may influence brain function circuits, mood, anxiety state, cognition, behavior, and medical physiology.
Primary Outcome
In vitro metagenomic sequencing and taxa analyses of gut microbial DNA isolated from stool samples.
Interventions
- OTHER Blood Sample
- OTHER Biological Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-09 |
What the finished NCT02693327 record still lists
NCT02693327 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Blood Sample is the first listed.
NCT02693327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02693327 about?
NCT02693327 is a clinical study titled "Microbiome and the Gut-Brain Axis". This research study will examine the relationship interconnecting medical body health, mental health, and microbes of the digestive tract in persons living with serious mental illnesses,as compared to persons without such disorders. Existing research suggests that interactions between digestive trac...
What is the current status of trial NCT02693327?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2016-04. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02693327?
The interventions under investigation include: Blood Sample (OTHER), Biological Sample (OTHER).
Who is sponsoring clinical trial NCT02693327?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia